These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 9827298)
1. Shock and cerebral infarct after rifampin re-exposure in a patient infected with human immunodeficiency virus. Martínez E; Collazos J; Mayo J Clin Infect Dis; 1998 Nov; 27(5):1329-30. PubMed ID: 9827298 [No Abstract] [Full Text] [Related]
2. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis]. Zierski M; Bek E Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146 [No Abstract] [Full Text] [Related]
3. Completing tuberculosis prophylaxis in jail: targeting treatment and a comparison of rifampin/pyrazinamide with isoniazid regimens. Lambert LA; Ijaz K; Navin TR Int J Tuberc Lung Dis; 2005 Feb; 9(2):230; author reply 230-1. PubMed ID: 15732748 [No Abstract] [Full Text] [Related]
4. Life-threatening, multiple hypersensitivity reactions induced by rifampicin in one patient with pulmonary tuberculosis. Luzzati R; Giacomazzi D; Franchi F; Barcobello M; Vento S South Med J; 2007 Aug; 100(8):854-6. PubMed ID: 17715477 [No Abstract] [Full Text] [Related]
5. [Therapy of tuberculosis in the adult]. Schrappe M; Wassermann K; Kroegel C Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936 [No Abstract] [Full Text] [Related]
6. Nutritional status of persons with HIV infection, persons with HIV infection and tuberculosis, and HIV-negative individuals from southern India. Swaminathan S; Padmapriyadarsini C; Sukumar B; Iliayas S; Kumar SR; Triveni C; Gomathy P; Thomas B; Mathew M; Narayanan PR Clin Infect Dis; 2008 Mar; 46(6):946-9. PubMed ID: 18279043 [TBL] [Abstract][Full Text] [Related]
7. [Desensitization to rifampicin. Apropos of a case]. Alonso MD; de la Hoz B; Cuevas M; Beick A Med Clin (Barc); 1996 Mar; 106(8):319. PubMed ID: 8667695 [No Abstract] [Full Text] [Related]
12. [Fatal anaphylactic shock caused by rifampicin in a patient with HIV infection]. Inmaculada Rubio M; Alvarez del Vayo C; Cisneros JM; Viciana P; Martínez-Marcos F Enferm Infecc Microbiol Clin; 1996 Mar; 14(3):200-1. PubMed ID: 8695696 [No Abstract] [Full Text] [Related]
13. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection. Stout JE Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147 [TBL] [Abstract][Full Text] [Related]
14. Rapid oral desensitization to isoniazid, rifampin, and ethambutol. Kim JH; Kim HB; Kim BS; Hong SJ Allergy; 2003 Jun; 58(6):540-1. PubMed ID: 12757467 [No Abstract] [Full Text] [Related]
15. Summaries for patients. Short-course treatment for latent tuberculosis is associated with more frequent liver injury than long-course treatment is. Ann Intern Med; 2002 Oct; 137(8):I32. PubMed ID: 12379094 [No Abstract] [Full Text] [Related]
19. Is the combination of pyrazinamide plus rifampicin safe for treating latent tuberculosis infection in persons not infected by the human immunodeficiency virus? Tortajada C; Martínez-Lacasa J; Sánchez F; Jiménez-Fuentes A; De Souza ML; García JF; Martínez JA; Caylà JA; Int J Tuberc Lung Dis; 2005 Mar; 9(3):276-81. PubMed ID: 15786890 [TBL] [Abstract][Full Text] [Related]
20. Drug-resistant tuberculosis of the brain in a two-year-old child. Mehta JB; Mejia E; Gallemore GH; Ramsey GF Tenn Med; 1998 Jul; 91(7):285-7. PubMed ID: 9659827 [No Abstract] [Full Text] [Related] [Next] [New Search]